Total Payments
$1.8M
2024 Payments
$92,714
Companies
12
Transactions
726
Payment Breakdown by Category
Other$935,296 (51.8%)
Consulting$751,414 (41.6%)
Travel$98,047 (5.4%)
Food & Beverage$17,564 (1.0%)
Research$3,094 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $929,554 | 216 | 51.5% |
| Consulting Fee | $751,414 | 36 | 41.6% |
| Travel and Lodging | $98,047 | 274 | 5.4% |
| Food and Beverage | $17,564 | 196 | 1.0% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $5,742 | 1 | 0.3% |
| Unspecified | $3,094 | 3 | 0.2% |
Payments by Type
General
$1.8M
723 transactions
Research
$3,094
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BTG International, Inc. | $737,164 | 92 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $416,648 | 212 | $0 (2024) |
| GENZYME CORPORATION | $284,674 | 141 | $0 (2023) |
| Shire North American Group Inc | $194,285 | 158 | $0 (2018) |
| Servier Pharmaceuticals LLC | $112,552 | 93 | $0 (2020) |
| Amgen Inc. | $23,687 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $17,860 | 6 | $0 (2023) |
| SERVIER AFFAIRES MEDICALES | $9,379 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $4,958 | 6 | $0 (2019) |
| EUSA Pharma (US) LLC | $4,070 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $92,714 | 76 | JAZZ PHARMACEUTICALS INC. ($51,276) |
| 2023 | $257,057 | 122 | JAZZ PHARMACEUTICALS INC. ($203,973) |
| 2022 | $214,234 | 112 | JAZZ PHARMACEUTICALS INC. ($118,547) |
| 2021 | $323,683 | 39 | BTG International, Inc. ($271,986) |
| 2020 | $380,324 | 28 | BTG INTERNATIONAL, INC. ($337,000) |
| 2019 | $152,099 | 74 | Servier Pharmaceuticals LLC ($58,693) |
| 2018 | $199,220 | 138 | Shire North American Group Inc ($110,712) |
| 2017 | $186,084 | 137 | Shire North American Group Inc ($83,573) |
All Payment Transactions
726 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | BTG International, Inc. | VORAXAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 12/20/2024 | BTG International, Inc. | VORAXAZE (Drug) | Food and Beverage | In-kind items and services | $101.64 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 12/17/2024 | BTG International, Inc. | VORAXAZE (Drug) | Travel and Lodging | Cash or cash equivalent | $228.93 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 12/16/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $148.92 | General |
| Category: Oncology | ||||||
| 12/03/2024 | BTG International, Inc. | VORAXAZE (Drug) | Travel and Lodging | Cash or cash equivalent | $483.95 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 12/02/2024 | BTG International, Inc. | VORAXAZE (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 12/02/2024 | BTG International, Inc. | VORAXAZE (Drug) | Travel and Lodging | Cash or cash equivalent | $110.00 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 12/02/2024 | BTG International, Inc. | VORAXAZE (Drug) | Travel and Lodging | Cash or cash equivalent | $35.00 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 11/07/2024 | BTG International, Inc. | VORAXAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 10/25/2024 | BTG International, Inc. | VORAXAZE (Drug) | Travel and Lodging | Cash or cash equivalent | $293.50 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 09/16/2024 | BTG International, Inc. | VORAXAZE (Drug) | Travel and Lodging | Cash or cash equivalent | $35.00 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 09/13/2024 | BTG International, Inc. | VORAXAZE (Drug) | Travel and Lodging | Cash or cash equivalent | $583.95 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 09/12/2024 | BTG International, Inc. | VORAXAZE (Drug) | Travel and Lodging | Cash or cash equivalent | $110.00 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 08/07/2024 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $8,372.00 | General |
| Category: Oncology | ||||||
| 06/28/2024 | Amgen Inc. | Blincyto (Biological) | Travel and Lodging | In-kind items and services | $115.98 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Amgen Inc. | Blincyto (Biological) | Travel and Lodging | In-kind items and services | $112.59 | General |
| Category: Oncology | ||||||
| 06/05/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,580.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/03/2024 | BTG International, Inc. | VORAXAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 06/01/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $248.57 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/31/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $144.42 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/30/2024 | BTG International, Inc. | VORAXAZE (Drug) | Travel and Lodging | Cash or cash equivalent | $290.75 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 05/29/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,340.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/29/2024 | BTG International, Inc. | VORAXAZE (Drug) | Food and Beverage | In-kind items and services | $90.97 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 05/25/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $497.95 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/21/2024 | BTG International, Inc. | VORAXAZE (Drug) | Travel and Lodging | Cash or cash equivalent | $747.95 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Health Economic Evaluation of Rasburicase (Faturec) for the treatment and prophylaxis of hyperuricemia | SANOFI-AVENTIS U.S. LLC | $2,549 | 2 |
| Patterns of use of rasburicase in community oncology programs and impact on tumor lysis syndrome outcomes | SANOFI-AVENTIS U.S. LLC | $544.97 | 1 |
About Dr. Scott Howard, MD
Dr. Scott Howard, MD is a Pediatric Hematology-Oncology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164425278.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Howard, MD has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $92,714 received in 2024. These payments were reported across 726 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($929,554).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Memphis, TN
- Active Since 05/23/2005
- Last Updated 10/30/2012
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1164425278
Products in Payments
- VORAXAZE (Drug) $737,164
- RYLAZE (Drug) $228,347
- ONCASPAR (Biological) $187,869
- ELITEK (Drug) $107,071
- ELITEK (Biological) $101,759
- ONCASPAR (Drug) $93,524
- CLOLAR (Drug) $37,461
- Erwinaze (Drug) $28,215
- Blincyto (Biological) $23,687
- Vitrakvi (Drug) $7,700
- NO PRODUCT DISCUSSED (Drug) $7,451
- Oncaspar (Drug) $5,500
- ERWINAZE (Drug) $4,453
- Sylvant (Biological) $4,070
- VYXEOS (Drug) $2,370
- ASPARLAS (Drug) $2,040
- DEFITELIO (Drug) $246.71
- Defitelio (Drug) $130.00
- Activase (Biological) $93.05
- Vonjo (Drug) $44.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Memphis
Dr. Ellis Neufeld, Md, MD
Pediatric Hematology-Oncology — Payments: $415,947
Pediatric Hematology-Oncology $415,947
Dr. Deepa Manwani, M.d, M.D
Pediatric Hematology-Oncology — Payments: $184,525
Pediatric Hematology-Oncology $184,525
Gary Myers, Md, MD
Pediatric Hematology-Oncology — Payments: $132,626
Pediatric Hematology-Oncology $132,626
Mr. Alberto Pappo, M.d, M.D
Pediatric Hematology-Oncology — Payments: $93,631
Pediatric Hematology-Oncology $93,631
Dr. Ching-Hon Pui, Md, MD
Pediatric Hematology-Oncology — Payments: $86,478
Pediatric Hematology-Oncology $86,478
Dr. Amar Gajjar, Md, MD
Pediatric Hematology-Oncology — Payments: $53,411
Pediatric Hematology-Oncology $53,411